Assessing salivary gland hypofunction--Part two.
Muzyka
Brian C
BC
Oral Medicine Residency Program, LSU Health Sciences Center, New Orleans, Louisiana, USA.
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002180:Candidiasis, Oral / Q000517:prevention & control; D003731:Dental Caries / Q000517:prevention & control; D006801:Humans; D008320:Maltose / Q000627:therapeutic use; D008409:Mastication / Q000502:physiology; D018721:Muscarinic Agonists / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D011812:Quinuclidines / Q000627:therapeutic use; D012463:Saliva / Q000187:drug effects / Q000378:metabolism; D013876:Thiophenes; D014987:Xerostomia / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*
D000891:Anti-Infective Agents, Local; D018721:Muscarinic Agonists; D011812:Quinuclidines; D013876:Thiophenes; D010862:Pilocarpine; D008320:Maltose; C059240:cevimeline